Cargando…
EsReflux Protocol: Epidemiological Study of Heartburn and Reflux-like Symptoms in Spanish Community Pharmacies
(1) Background: Heartburn and reflux discomfort are frequent reasons for consultation at the community pharmacy. To facilitate the assistance work of the community pharmacist and its coordination between different levels of care, a group of experts in Community Pharmacy, Primary Care, and Gastroente...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407743/ https://www.ncbi.nlm.nih.gov/pubmed/36011453 http://dx.doi.org/10.3390/ijerph19169807 |
_version_ | 1784774437488295936 |
---|---|
author | López-Pintor, Elsa Puig-Moltó, María Lumbreras, Blanca |
author_facet | López-Pintor, Elsa Puig-Moltó, María Lumbreras, Blanca |
author_sort | López-Pintor, Elsa |
collection | PubMed |
description | (1) Background: Heartburn and reflux discomfort are frequent reasons for consultation at the community pharmacy. To facilitate the assistance work of the community pharmacist and its coordination between different levels of care, a group of experts in Community Pharmacy, Primary Care, and Gastroenterology have recently worked on an algorithm to manage these symptoms in the community pharmacy (Professional Pharmaceutical Service). The objective of this study is to analyze the clinical and sociodemographic characteristics of patients with heartburn and/or reflux-like symptoms who go to a community pharmacy, and to evaluate the clinical and humanistic results after the implementation of a Professional Pharmaceutical Service. (2) Methods: A pre-post study will be carried out to evaluate clinical and humanistic results after the implementation of a Professional Pharmaceutical Service. We will include 1200 patients who ask for advice or get a non-prescription medication due to acid and/or reflux symptoms in 240 Spanish pharmacies. Clinical data will be collected at baseline and 15 days after the pharmaceutical intervention. The GERD Impact Scale (GIS) questionnaire will be applied to assess changes in heartburn/reflux-like symptoms and quality of life after the intervention. |
format | Online Article Text |
id | pubmed-9407743 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94077432022-08-26 EsReflux Protocol: Epidemiological Study of Heartburn and Reflux-like Symptoms in Spanish Community Pharmacies López-Pintor, Elsa Puig-Moltó, María Lumbreras, Blanca Int J Environ Res Public Health Protocol (1) Background: Heartburn and reflux discomfort are frequent reasons for consultation at the community pharmacy. To facilitate the assistance work of the community pharmacist and its coordination between different levels of care, a group of experts in Community Pharmacy, Primary Care, and Gastroenterology have recently worked on an algorithm to manage these symptoms in the community pharmacy (Professional Pharmaceutical Service). The objective of this study is to analyze the clinical and sociodemographic characteristics of patients with heartburn and/or reflux-like symptoms who go to a community pharmacy, and to evaluate the clinical and humanistic results after the implementation of a Professional Pharmaceutical Service. (2) Methods: A pre-post study will be carried out to evaluate clinical and humanistic results after the implementation of a Professional Pharmaceutical Service. We will include 1200 patients who ask for advice or get a non-prescription medication due to acid and/or reflux symptoms in 240 Spanish pharmacies. Clinical data will be collected at baseline and 15 days after the pharmaceutical intervention. The GERD Impact Scale (GIS) questionnaire will be applied to assess changes in heartburn/reflux-like symptoms and quality of life after the intervention. MDPI 2022-08-09 /pmc/articles/PMC9407743/ /pubmed/36011453 http://dx.doi.org/10.3390/ijerph19169807 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Protocol López-Pintor, Elsa Puig-Moltó, María Lumbreras, Blanca EsReflux Protocol: Epidemiological Study of Heartburn and Reflux-like Symptoms in Spanish Community Pharmacies |
title | EsReflux Protocol: Epidemiological Study of Heartburn and Reflux-like Symptoms in Spanish Community Pharmacies |
title_full | EsReflux Protocol: Epidemiological Study of Heartburn and Reflux-like Symptoms in Spanish Community Pharmacies |
title_fullStr | EsReflux Protocol: Epidemiological Study of Heartburn and Reflux-like Symptoms in Spanish Community Pharmacies |
title_full_unstemmed | EsReflux Protocol: Epidemiological Study of Heartburn and Reflux-like Symptoms in Spanish Community Pharmacies |
title_short | EsReflux Protocol: Epidemiological Study of Heartburn and Reflux-like Symptoms in Spanish Community Pharmacies |
title_sort | esreflux protocol: epidemiological study of heartburn and reflux-like symptoms in spanish community pharmacies |
topic | Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407743/ https://www.ncbi.nlm.nih.gov/pubmed/36011453 http://dx.doi.org/10.3390/ijerph19169807 |
work_keys_str_mv | AT lopezpintorelsa esrefluxprotocolepidemiologicalstudyofheartburnandrefluxlikesymptomsinspanishcommunitypharmacies AT puigmoltomaria esrefluxprotocolepidemiologicalstudyofheartburnandrefluxlikesymptomsinspanishcommunitypharmacies AT lumbrerasblanca esrefluxprotocolepidemiologicalstudyofheartburnandrefluxlikesymptomsinspanishcommunitypharmacies |